Division of Eurofins Scientific SE
Latest From Cylex Inc.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, Alliance, and Financing activity.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.
In Vitro Diagnostics
- Chemistry, Immunoassay
- Therapeutic Areas
- Immune Disorders
- North America
- Parent & Subsidiaries
- Eurofins Scientific SE
- Senior Management
Brad L Stewart, Chmn., Pres. & CEO
Jianrong Lou, PhD, Dir., Research & Prod. Dev.
- Contact Info
Phone: (410) 964-0236
8980-I Old Annapolis Rd.
Columbia, MD 21045
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.